Eli Lilly and Company, a global pharmaceutical leader, announced plans to launch its blockbuster weight-loss drug Mounjaro (tirzepatide) in emerging markets by…
Obesity is not a one-size-fits-all condition. It manifests in diverse ways, influenced by factors like fat distribution, underlying causes, and…
In the relentless battle against obesity, scientists have uncovered a surprising new player: the protein CD44. Groundbreaking research published in The American…
Key Highlights What is Liraglutide? Liraglutide is a GLP-1 receptor agonist, a class of medications revolutionizing type 2 diabetes treatment…
The fight against obesity is entering an exciting new era. With blockbuster drugs like Wegovy (semaglutide) and Zepbound (tirzepatide) already…
Key Points Background Current weight-loss methods, including lifestyle changes, surgery, and drugs like Wegovy and Zepbound, often result in both…
